Literature DB >> 2315310

Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats.

T Takano-Yamamoto1, G A Rodan.   

Abstract

High-affinity nuclear binding sites for 17 beta-estradiol (17 beta E2) were recently found in bone cells; however, the mechanism by which estrogen exerts its effect on bone in vivo is still unknown. To study if estrogen acts on bone directly, we used an experimental model in which test substances are infused locally into rat femur trabecular bone. Sprague-Dawley rats weighing 150-160 g were ovariectomized (OVX) and 14 days later a polyethylene tube (1 mm in diameter) connected to an Alzet osmotic minipump was implanted into the distal femur 9 mm from the joint. 17 beta E2 (24 microliters/day at 0.01-1 nM), 17 alpha-estradiol (17 alpha E2) (24 microliters/day at 1 nM), or phosphate-buffered saline (NaCl, 8 g/liter; KCl, 0.2 g/liter; KH2PO4, 0.2 g/liter; Na2HPO4.7H2O, 2.16 g/liter) was infused for 8 days. The contralateral limb remained intact. Animals were sacrificed and bones were examined by histomorphometry. Ovariectomy caused a 50% loss in trabecular bone volume (TBV) in the secondary spongiosa (from 20.3% +/- 1.7% to 9.6% +/- 1.1%; mean +/- SEM), a 2-fold increase in osteoclast number (to 4.0 +/- 0.4 per mm), a 3-fold increase in relative resorption surfaces (to 24.8% +/- 2.9%), a 9-fold increase in osteoblast number (to 11.3 +/- 2.1 per mm), and an 8-fold increase in relative osteoid surface (to 9.6% +/- 1.7%). The local infusion of 17 beta E2 for 8 days into OVX rats (i) restored the TBV dose dependently to 75% and 85% of control (non-OVX) levels, at 0.1 nM and 1 nM 17 beta E2, respectively; (ii) decreased osteoclast number and the relative resorption surface to control (non-OVX) levels; and (iii) further increased osteoblast number and the relative osteoid surface dose dependently (by 5-fold at 1 nM 17 beta E2). Phosphate-buffered saline infusion was without effect. Infusion of 17 alpha E2 had no effect on TBV, osteoclast number, or resorption surface but increased slightly the osteoblast number and the osteoid surface. Its potency was 1/100 that of 17 beta E2. The local infusion of 17 beta E2 or 17 alpha E2 had no effect on body or uterine weight. We conclude from these findings that estrogen delivered directly to the bone of OVX rats in vivo at 2.4 and 24 fmol/day acted locally to inhibit bone resorption and stimulate bone formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315310      PMCID: PMC53648          DOI: 10.1073/pnas.87.6.2172

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Ovarian steroids modulate the action of calcitonin in women.

Authors:  F Pansini; C M Bergamini; A Bellinazzi; M Andreoli; G Perri; B Bagni; G Mollica
Journal:  J Endocrinol       Date:  1988-01       Impact factor: 4.286

2.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

Authors:  T K Gray; T C Flynn; K M Gray; L M Nabell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  Endocrinology       Date:  1988-01       Impact factor: 4.736

Review 4.  Growth factors and the regulation of bone remodeling.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 5.  Cell proliferation of estrogen-sensitive cells: the case for negative control.

Authors:  A M Soto; C Sonnenschein
Journal:  Endocr Rev       Date:  1987-02       Impact factor: 19.871

6.  17 Beta-estradiol inhibits the oxidative metabolism of U937 cells indirectly via lymphocytes.

Authors:  G Sivam; M S Cohen; R C Dodd; T K Gray
Journal:  Endocrinology       Date:  1987-09       Impact factor: 4.736

7.  17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture.

Authors:  D P Edwards; W L McGuire
Journal:  Endocrinology       Date:  1980-10       Impact factor: 4.736

8.  Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17 beta-estradiol in vivo.

Authors:  J H Feyen; L G Raisz
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

9.  Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat.

Authors:  F Ismail; S Epstein; M D Fallon; S B Thomas; T A Reinhardt
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

10.  Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; C C Walsh; L A Ignaszewski
Journal:  Bone       Date:  1986       Impact factor: 4.398

View more
  32 in total

1.  Effect of 17beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17beta-estradiol serum kinetics and bone mass in rats.

Authors:  F Bauss; A Esswein; K Reiff; G Sponer; B Müller-Beckmann
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

2.  Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.

Authors:  J Chow; J H Tobias; K W Colston; T J Chambers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats.

Authors:  D Egrise; D Martin; P Neve; A Vienne; M Verhas; A Schoutens
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  The in vivo role of bone marrow fibroblast-like stromal cells.

Authors:  D J Simmons
Journal:  Calcif Tissue Int       Date:  1996-03       Impact factor: 4.333

5.  Estrogen receptor-α expression in neuronal cells affects bone mass.

Authors:  Claes Ohlsson; Cecilia Engdahl; Anna E Börjesson; Sara H Windahl; Erik Studer; Lars Westberg; Elias Eriksson; Antti Koskela; Juha Tuukkanen; Andree Krust; Pierre Chambon; Hans Carlsten; Marie K Lagerquist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

6.  A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.

Authors:  Gaurav Swarnkar; Kunal Sharan; Jawed A Siddiqui; Jay Sharan Mishra; Kainat Khan; Mohd Parvez Khan; Varsha Gupta; Preeti Rawat; Rakesh Maurya; Anil K Dwivedi; Sabyasachi Sanyal; Naibedya Chattopadhyay
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Proliferative responses to estradiol, IL-1 alpha and TGF beta by cells expressing alkaline phosphatase in human osteoblast-like cell cultures.

Authors:  D J Rickard; M Gowen; B R MacDonald
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

8.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

9.  Regulation of ER molecular chaperone prevents bone loss in a murine model for osteoporosis.

Authors:  Shin-ichiro Hino; Shinichi Kondo; Kazuya Yoshinaga; Atsushi Saito; Tomohiko Murakami; Soshi Kanemoto; Hiroshi Sekiya; Kazuyasu Chihara; Yuji Aikawa; Hideaki Hara; Takashi Kudo; Tomohisa Sekimoto; Taro Funamoto; Etsuo Chosa; Kazunori Imaizumi
Journal:  J Bone Miner Metab       Date:  2009-09-17       Impact factor: 2.626

Review 10.  Mineral metabolism and bone disease after bariatric surgery and ways to optimize bone health.

Authors:  Dave H Schweitzer
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.